 |
Prospector
Profile
07.1111
|
| |
| Cogenco International, Inc. |
NAICS |
221112 |
| 6400 South Fiddler's Green Circle
Greenwood Village, CO 80111 |
Description |
Power Generation |
| (303) 221-3680 |
Employees |
11 |
|
Revenue |
(mil) |
0.0010 |
| |
Income |
(mil) |
-3.2370 |
| |
Assets |
(mil) |
0.3830 |
| |
Liability |
(mil) |
0.0030 |
| |
(for the year ended 2006-03-31) |
| |
|
Category:
Audit Concerns
|
| |
|
Event:
Cuasey Demgen & Moore, Inc. raised doubts about the ability of Cogenco International, Inc. to continue as a going concern after auditing its financial statements. The auditor notes that the Company has incurred significant losses from inception to date and does not have sufficient funds on hand to continue to fund operations without a capital infusion.
|
| |
|
Intellectual Property:
As of December 31, 2004, the Company's DMI BioSciences, Inc. subsidiary owned 11 patents and more than 60 pending patent applications in the United States and throughout the rest of the world. The patents cover the wide variety of therapeutic and diagnostic inventions that have been developed by DMI, including compositions of matter, methods of use, manufacturing methods, novel diagnostic assays and medical devices. The development and protection of trademarks covering corporate and product names, logos, trade dress, etc. is an important aspect of DMI's intellectual property efforts. [SEC Filing 10-KSB 07-11-07]
|
| |
|
Description:
The Company is engaged in the cogeneration business, which is the simultaneous production of power, either mechanical or electrical, and useful thermal energy, so that the waste heat which is a by-product of one process becomes the energy source for the other.
|
| |
|
Officers:
David W. Brenman (Pres., Sec., Treas. & Dir.); Albert Brenman (Dir.); Robert A. Melnick (Dir.)
|
| |
|
Auditor:
Cuasey Demgen & Moore, Inc.
|
| |
|
Securities:
Common Stock-Symbol CGNN.PK; Other OTC;
2,656,256 common shares outstanding as of May 31, 2007.
|
| |
| |
| |
| return to main page |
|
|
